ENHANCING ONCOLOGY EXPLORATION WITH BUILT-IN KRAS ASSAY COMPANIES AND RAS ASSAYS

In the rapidly evolving field of oncology research, correct and efficient mutation screening is important for creating qualified therapies. The KRAS solutions Platform performs a pivotal function in this landscape by providing comprehensive methods for KRAS mutation profiling and Assessment. KRAS mutations, present in close to ninety five% of RAS-c